Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis

International Journal of Biological Macromolecules

Volumn 69, Issue , 2014, Pages 124-136

  Cevher, Erdal ^a   Açma, Ayşe ^a   Sinani, Genada ^a   Aksu, Buket ^b   Zloh, Mire ^c   Mülazi moǧlu, Lütfiye ^d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Santa Farma Pharmaceuticals   (Turkey)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^d MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cyclodextrin; Itraconazole; Mucoadhesion; Vaginal candidiasis; Vaginal tablet

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; ITRACONAZOLE; METHYL BETA CYCLODEXTRIN; ADHESIVE AGENT; ANTIFUNGAL AGENT; DRUG CARRIER; TABLET;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CLINICAL EFFECTIVENESS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; FEMALE; FUNGAL STRAIN; HUMAN; NONHUMAN; PH MEASUREMENT; PHASE TRANSITION; PROCESS OPTIMIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TABLET FORMULATION; VAGINA CANDIDIASIS; X RAY DIFFRACTION; ANIMAL; BOVINAE; CANDIDIASIS; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG EFFECTS; MEDICINAL CHEMISTRY; MICROBIOLOGY; SOLUBILITY; TABLET; VAGINA; VAGINA DISEASE;

ADHESIVES; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; CATTLE; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DRUG CARRIERS; FEMALE; ITRACONAZOLE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SOLUBILITY; TABLETS; VAGINA; VAGINAL DISEASES;

EID: 84901594342     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.05.033     Document Type: Article

References (76)

1. Enoch D.A., Ludlam H.A., Brown N.M. J. Med. Microbiol. 2006, 55:809-818.
2. Sobel J.D. Expert Opin. Pharmacol. 2002, 3:1059-1065.
3. De Beule K., Van Gestel J. Drugs 2001, 61:27-37.
4. Piérard G.E., Arrese J.E., Piérard-Franchimont C. Expert Opin. Pharmacother. 2000, 1:287-304.
5. Heykants J., Van Peer A., Van de Velde V., Van Rooy P., Meuldermans W., Lavrijsen K., Woestenborghs R., Van Cutsem J., Cauwenbergh G. Mycoses 1989, 32:67-87.
6. Jung J.Y., Yoo S.D., Lee S.H., Kim K.H., Yoon D.S., Lee K.H. Int. J. Pharm. 1999, 187:209-218.
7. Davis M.E., Brewster M.E. Nat. Rev. Drug. Discov. 2004, 3:1023-1035.
8. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. Pharm. Res. 1995, 12:413-420.
9. Como J.A., Dismukes W.E. N. Engl. J. Med. 1994, 330:263-272.
10. Park C.W., Mansour H.M., Oh T.O., Kim J.Y., Ha J.M., Lee B.J., Chi S.C., Rhee Y.S., Park E.S. Int. J. Pharm. 2012, 436:652-658.
11. Andrews J.M. J. Antimicrob. Chemother. 2001, 48:5-16.
12. Hassan H.A., Al-Marzouqi A.H., Jobe B., Hamza A.A., Ramadan G.A. J. Pharm. Biomed. Anal. 2007, 45:243-250.
13. Janssens S., de Armas H.N., Remon J.P., Van den Mooter G. Eur. J. Pharm. Sci. 2007, 30:288-294.
14. Liu D., Fei X., Wang S., Jiang T., Desen S. Asian J. Pharm. Sci. 2006, 1:213-221.
15. Mellaerts R., Mols R., Jammaer J.A., Aerts C.A., Annaert P., Van Humbeeck J., Van den Mooter G., Augustijns G., Martens J.A. Eur. J. Pharm. Biopharm. 2008, 69:223-230.
16. Sathigari S.K., Ober C.A., Sanganwar G.P., Gupta R.B., Babu R.J. J. Pharm. Sci. 2011, 100:2952-2965.
17. Loftsson T., Brewster M.E. J. Pharm. Sci. 1996, 85:1017-1025.
18. Szejtli J. Chem. Rev. 1998, 98:1743-1753.
19. Del Valle E.M. Process. Biochem. 2004, 39:1033-1046.
20. Munoz de la Pena A., Ndou T.T., Zung J.B., Greene K.L., Live D.H., Warner I.M. J. Am. Chem. Soc. 1991, 113:1572-1577.
21. Thompson D.O. Crit. Rev. Ther. Drug. Carrier. Syst. 1997, 14:1-104.
22. Rajewski R.A., Stella V.J. J. Pharm. Sci. 1996, 85:1142-1168.
23. Lee S.Y., Jung I.I., Kim J.K., Lim G.B., Ryu J.H. J. Supercrit. Fluid 2006, 44:400-408.
24. Buchanan C.M., Buchanan N.L., Edgar K.J., Klein S., Little J.L., Ramsey M.G., Ruble K.M., Vincent J.W., Wempe M.F. J. Pharm. Sci. 2007, 96:3100-3116.
25. Chang J.Y., Oh Y.K., Kong H.S., Kim E.J., Jang D.D., Nam K.T., Kim C.K. J. Control. Release 2002, 82:39-50.
26. Mirza M.A., Ahmad S., Mallick M.N., Manzoor N., Talegaonkar S., Iqbal Z. Colloids Surf. B. Biointerfaces 2013, 103:275-282.
27. Valenta C. Adv. Drug. Del. Rev. 2005, 57:1692-1712.
28. Dobaria N.B., Badhan A.C., Mashru R.C. AAPS PharmSciTech 2009, 10:951-959.
29. Higuchi T., Connors K.A. Adv. Anal. Chem. Instrum. 1965, 4:117-212.
30. Woestenborgh R., Lorreyne W., Heykants J. J. Chromatogr. Biomed. Appl. 1987, 413:332-337.
31. Jeener J., Meier B.H., Ernst B.P., Ernst R.R. J. Chem. Phys. 1979, 71:4546-4553.
32. Mohamadi F., Richards N., Guida W., Liskamp R., Lipton M., Caulfield C., Chang G., Hendrickson T., Still W. J. Comput. Chem. 1990, 11:440-467.
33. Cramer C.J., Truhlar D.G. Continuum solution model: classical and quantum mechanical implementations. Reviews in Computational Chemistry 1995, 1-72. VCH, New York. K.B. Lipkowitz, D.B. Boyd (Eds.).
34. Still W.C., Tempczyk A., Hawley R.C., Hendrickson T. J. Am. Chem. Soc. 1990, 112:6127-6129.
35. Shenkin P.S., McDonald D.Q. J. Comput. Chem. 1994, 15:899-916.
36. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard. Document M27-A 1997, National Committee for Clinical Laboratory Standards, Wayne, PA.
37. European Pharmacopoeia, 7th ed., 2013.
38. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. J. Pharm. Sci. 1983, 72:1189-1191.
39. Peppas N.A. Pharm. Acta. Helv. 1985, 60:110-111.
40. Ritger P.L., Peppas N.A. J. Control. Release 1987, 5:37-42.
41. Haria M., Bryson H.M., Goa K.L. Drugs 1996, 51:585-620.
42. Peeters J., Neeskens P., Tollenaere J.P., Van Remoortere P., Brewster M.E. J. Pharm. Sci. 2002, 91:1414-1422.
43. Li P., Tabibi E., Yalkowsky S.H. J. Pharm. Sci. 1998, 87:1535-1537.
44. Kelloff G.J., Boone C.W., Crowell J.A., Steele V.E., Lubet R.A., Doody L.A. J. Cell. Biochem. 1996, 265:1-28.
45. Loftsson T., Olafsdottir B., Frioriksdottir H., Jonsdottir S. Eur. J. Pharm. Sci. 1993, 1:95-101.
46. Pitha J., Hoshino T. Int. J. Pharm. 1992, 80:243-251.
47. Reer O., Muller B.W. Eur. J. Pharm. Biopharm. 1993, 39:105-111.
48. Zung J.B., Pena A.M., Ndou T.T., Warner I.M. J. Phys. Chem. 1991, 95:6701-6709.
49. Yalkowsky S.H., Solubility Solubilization in Aqueous Media 1999, American Chemical Society, Washington, DC.
50. Li P., Zhao L., Yalkowsky S.H. J. Pharm. Sci. 1999, 88:1107-1111.
51. Jambhekar S., Casella R., Maher T. Int. J. Pharm. 2004, 270:149-166.
52. Higuchi T., Kristiansen H. J. Pharm Sci. 1970, 59:1601-1608.
53. Ahmed M.O., El-Gibaly I., Ahmed S.M. Int. J. Pharm. 1998, 171:111-121.
54. Cevher E., Sensoy D., Zloh M., Mülazimoǧlu L. J. Pharm. Sci. 2008, 97:4319-4335.
55. Al-Marzouqi A.H., Shehatta I., Jobe B., Dowaidar A. J. Pharm. Sci. 2006, 95:292-304.
56. Challa R., Alka A., Javed A., Khar R.K. AAPS PharmSciTech 2005, 6:E329-E357.
57. Korteweg G.C., Szabo K.L., Rutten A.M., Hoogerheide J.C. Antibiot. Chemother. 1963, 11:261-272.
58. Hamada H., Ishihara K., Masuoka N., Mikuni K., Nakajima N. J. Biosci. Bioeng. 2006, 102:369-371.
59. Tansho S., Abe S., Ishibashi H., Torii S., Otani H., Ono Y., Yamaguchi H. J. Infect. Chemother. 2006, 12:355-362.
60. Savolainen J., Jarvinen K., Matilainen L., Jarvinen T. Int. J. Pharm. 1998, 165:69-78.
61. Zhu X.L., Wang H.B., Chen Q., Yang W.C., Yang G.F. J. Agric. Food. Chem. 2007, 55:3535-3539.
62. Tur K.M., Ching H.S. Int. J. Pharm. 1998, 160:61-74.
63. Fabregas J.L., Garcia N. Drug. Dev. Ind. Pharm. 1995, 21:1689-1696.
64. Jug M., Bećirević-Laćan M. Eur. J. Pharm. Sci. 2004, 21:251-260.
65. Baloglu E., Ozyazici M., Hizarcioglu S.Y., Karavana H.A. Farmaco 2003, 58:391-396.
66. Huntsberger J.R. J. Adhesion 1989, 12:3-12.
67. Nafee N.A., Ismail F.A., Boraie N.A., Mortada L.M. Drug. Dev. Ind. Pharm. 2004, 30:985-993.
68. Peppas N.A., Bury P.A. J. Control. Release 1985, 2:257-275.
69. Bottenberg P., Cleymaet R., de Muynck C., Remon J.P., Coomans D., Michotte Y., Slop D. J. Pharm. Pharmacol. 1991, 43:457-464.
70. Noveon Pharmaceutical Bulletin 16: Bioadhesion 2014, Noveon Inc., Cleveland, Ohio.
71. Sharma G., Jain S., Tiwary A.K., Kaur G. Acta Pharm. 2006, 56:337-345.
72. Mortazavi S.A., Smart J.D. J. Pharm. Pharmacol. 1994, 48:285-287.
73. Ranga Rao K.V., Buri P. Int. J. Pharm. 1989, 52:265-270.
74. Khamanga S.M., Walker R.B. Drug. Dev. Ind. Pharm. 2006, 32:1139-1148.
75. Fassihi R.A., Ritschel W.A. J. Pharm. Sci. 1993, 82:750-754.
76. Baloglu E., Ozyazici M., Hi zarci oglu S.Y., Şenyigit T., Özyurt D., Pekcetin C. Pharm. Dev. Technol. 2006, 11:477-484.